Power Law company profile

Coherus Oncology

Biotech & Life Sciences · Redwood City, United States · Founded 2010 · IPO 2014 Unicorn

Develops, manufactures and commercializes biologic therapeutics for oncology and inflammatory diseases

Valuation

$134M

Market cap · May/2026

Revenue

$42M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

6 investors on Coherus Oncology's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Helix Ventures

Medpace

Series B+ 4 investors entered at this stage

Lilly Ventures

KKR

RA Capital Management

Daiichi Sankyo

Global footprint

Where Coherus Oncology has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States99.5%

🇨🇦 Canada0.5%

2 countries shown

Web traffic by country

8.8K monthly visits
across markets

🇺🇸 United States63.6%

🇯🇵 Japan14.8%

🇬🇧 United Kingdom12.5%

🇮🇳 India9.1%

🇮🇹 Italy0%

Top 5 markets shown

Patent intelligence

$40M patent portfolio · 49 active families

Estimated portfolio value

$40M

30.1% of market cap · 50.5× smaller than top peer Ablynx ($2B)

49 active patent families

Where Coherus Oncology innovates Molecular biologyCarcinosisAntiendomysial antibodiesImmunologyAnti antibody

Where Coherus Oncology concentrates vs peers

Each axis is a top-10 topic across Coherus Oncology and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Coherus Oncology

An AI-synthesized read of the highest-engagement posts about Coherus Oncology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Coherus Oncology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles